Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Humacyte, Inc. Director's Dealing 2024

Jun 17, 2024

33410_dirs_2024-06-17_9823a35c-a56a-4f66-928b-b959fd52b7ae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Humacyte, Inc. (HUMA)
CIK: 0001818382
Period of Report: 2024-06-11

Reporting Person: Jones Keith Anthony (Director)

More from Humacyte, Inc.

Regulatory Filings 2026
May 14
Regulatory Filings 2026
Apr 24
Major Shareholding Notification 2026
Mar 24
Regulatory Filings 2026
Mar 19
Regulatory Filings 2026
Mar 19
Major Shareholding Notification 2026
Jan 9
Regulatory Filings 2025
Dec 16
Regulatory Filings 2025
Dec 16
Regulatory Filings 2025
Dec 15
Regulatory Filings 2025
Dec 15
View all filings →